Personal care treatments

Pennsylvania Taxpayers Paid $16 Million For Childhood Sex Reassignment Treatments

Changing sex is expensive. But low-income children in Pennsylvania are covered for medical assistance through the Children’s Health Insurance Program (CHIP).

Pennsylvania taxpayers unknowingly paid more than $16 million under Democratic Gov. Tom Wolf’s administration to fund sex reassignment and gender transition services for children.

Every year since 2015, when Wolf took office, state spending on child sex reassignment treatments has increased, according to data obtained by the Pennsylvania Family Institute.

In 2015, Pennsylvania paid $78,000 for sex reassignment services for children under 18. In 2021, the state spent $3.9 million.

The Pennsylvania Department of Social Services (PA DHS) provided data to the Pennsylvania Family Institute through a right-to-know request seeking records reflecting the amount of money Pennsylvania spent on minors through CHIP to receive “gender reassignment and transition services and medications from 2015 to present.

“This level of harm inflicted on children by the state is reprehensible,” Alexis Sneller of the Pennsylvania Family Institute said in a statement. “While we knew the Wolf administration was funding services related to these irreversible procedures on minors, now seeing the exact numbers – millions spent on these harmful acts – is still shocking.”

Taxpayer funded treatments

The data includes basic codes and descriptions for each treatment, but it is not known how many treatments were used for each patient, so the total number of minors who received the drugs and procedures is unknown.

Treatments listed in the data include androgenic agents, which are used in the transition from female to male; and estrogenic agents, which are feminizing hormones potent enough to cause the development of breasts in a man.

Some girls received Yuvafem, a vaginal insert tablet used to reduce symptoms of menopause, and Estring, another menopause insert in the form of a flexible ring that continuously releases estrogen. Estring’s safety indications include a warning that use of the product may increase the risk of developing dementia and that estrogen should be used at the lowest possible dose and only for as long as needed.

Many treatments are hormones in the form of gels, creams, patches and pills normally used for menopausal and post-menopausal women. Others are testosterone substitutes, normally used in men who don’t make enough on their own.

All are prescribed for off-label use.

“Since no medications are specifically for gender reassignment or transitioning services, pharmacy claims were only included when the recipient had previously been diagnosed with an identity disorder. status or personal history of a sex reassignment diagnosis within the specified service dates,” the PA DHS said in a memo. included in the response to the right to know request. “The data is restricted to recipients aged 18 and under.”

The data is from January 1, 2015 to October 21, 2022.

Homeless children get gender treatment

At a Pennsylvania House Health Committee hearing, Nadia Dowshen, co-founder of the Children’s Hospital of Philadelphia (CHOP) Gender Clinic, said her clinic receives referrals from foster families and shelters for the -shelter.

“We really get referrals from various resources,” Dowshen said. “We get a lot more referrals from institutions and other youth-serving professionals who work with young people in other capacities, sometimes from the foster care system or the mental health system, or through shelters for homelessness for young people who need support. ”

In another presentation, Dowshen praised Dr. Rachel Levine, calling the former Pennsylvania health secretary a “wonderful advocate…doing incredible work to ensure young people have health coverage.” these drugs.

Levin is a transgender person who served in Pennsylvania until President Joe Biden appointed Levine assistant secretary of the US Department of Health and Human Services. Levine is a former professor of pediatrics and psychiatry at Penn State College of Medicine and a longtime advocate for “gender-affirming care,” which includes puberty blockers, hormone treatments, and surgeries with life-altering consequences. children and teenagers who want to change their bodies and live like the opposite sex.

Gender-affirming care in children is controversial because many treatments are irreversible and decisions about the medical management of childhood gender are made before the child’s brain is fully developed.

“When Governor Wolf took office, he unilaterally changed state policy to cover things like double mastectomies to remove healthy breasts from underage girls and irreversible experimental hormones for children,” Emily Kreps said. of the Pennsylvania Family Institute in a statement. “The same drugs used to chemically castrate convicted sex offenders are funded by taxpayer dollars for minors.”

The transgender industry appears to be driven by both monetary profit and the radical gender ideology that makes it possible, she said.


Beth Brelje is a national investigative journalist covering politics, wrongdoing and the stories of ordinary people facing extraordinary circumstances. Send her your story ideas: [email protected]